Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Evidence for the effectiveness and cost-savings of workplace wellness programs (WWPs) is varied, likely due to the variability in program design, as not all WWPs meet the five-point criteria of a "comprehensive WWP" set by the U.S. Centers for Disease Control and Prevention. A 2019 study of changes in cardiovascular disease (CVD) risk for those enrolled in a comprehensive WWP found that nearly half of enrolled employees with moderate to high CVD risk improved their risk compared to the initial predictions. This study extends those findings by evaluating the cost-savings and return on investment (ROI) resulting from participants' CVD risk reduction from the employer's perspective.

Method: Cost-savings related to CVD risk were extrapolated using two studies that provided associated cost-savings for individuals participating in a WWP. Utilizing reference groups used in previous studies, we calculated cost-savings per 1% reduction in CVD risk using our population's specific CVD risk and our program-specific costs. The cost-savings were annualized per person within each risk category.

Results: Across all risk categories, cost-savings were USD 1224 per individual or USD 4.90 ROI for every USD 1 spent. Those at risk had a higher ROI per USD 1.00 spent (USD 35.4 and USD 19.2 for males and females, respectively) than those with minimal risk. However, even those with minimal risk showed a positive ROI (USD 0.3 and USD 5.0 for males and females, respectively).

Conclusions/application To Practice: Investment in WWPs should prioritize programs that include all five elements of the standards established by the U.S Centers for Disease Control and Prevention. Well-designed and comprehensive WWPs can effectively impact employee health and lead to a positive ROI and cost-savings for employers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11640894PMC
http://dx.doi.org/10.3390/healthcare12232358DOI Listing

Publication Analysis

Top Keywords

cvd risk
24
risk
13
roi usd
12
impact employee
8
cardiovascular disease
8
risk reduction
8
cost-savings
8
centers disease
8
disease control
8
control prevention
8

Similar Publications

The Grams model, designed to predict adverse event risks in advanced chronic kidney disease (CKD) patients, was evaluated in a Chinese cohort of 1,333 patients with eGFR below 30 mL/min/1.73 m. The model demonstrated moderate to good discrimination across outcomes, performing well in predicting kidney replacement therapy (KRT) but overestimating the risks of cardiovascular disease (CVD) and mortality.

View Article and Find Full Text PDF

Background And Aims: Diabetes mellitus (DM) commonly coexists with non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD), and when combined with these two conditions, the risk of all-cause mortality and developing cardiovascular diseases (CVD) increases. The present community-based cohort study aimed to elucidate the combined effect of NAFLD and CKD on CVD and mortality risks in new-onset DM patients.

Methods And Results: After the exclusion of participants failing to meet the inclusion criteria, 11,328 eligible participants (mean age: 58.

View Article and Find Full Text PDF

Lipoprotein(a) in neoplastic transformation.

Clin Chim Acta

September 2025

Department of Cardiology, Haikou Hospital of Traditional Chinese Medicine, No. 45 Jinpan Road, Longhua District, Haikou 5700100 Hainan, China; Cardiometabolic Center, State Key Laboratory of Cardiovascular Diseases, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Med

Cardiovascular diseases and cancer are top global causes of death, sharing risk factors and treatment strategies. Although dyslipidemia is linked to both, its exact roles are unclear. Recent studies suggest a potential association between plasma lipoprotein(a) levels and cancer risk.

View Article and Find Full Text PDF

Cardiovascular Risk Prediction in Older Adults.

Curr Atheroscler Rep

September 2025

Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, 521 19th Street South-GSB 444, Birmingham, AL, 35233, USA.

Purpose Of Review: This review examines cardiovascular disease (CVD) risk prediction models relevant to older adults, a rapidly expanding population with elevated CVD risk. It discusses model characteristics, performance metrics, and clinical implications.

Recent Findings: Some models have been developed specifically for older adults, while several others consider a broader age range, including some older individuals.

View Article and Find Full Text PDF

Background The prognostic value of baseline visual emphysema scoring at low-dose CT (LDCT) in lung cancer screening cohorts is unknown. Purpose To determine whether a single visual emphysema score at LDCT is predictive of 25-year mortality from all causes, chronic obstructive pulmonary disease (COPD), and cardiovascular disease (CVD). Materials and Methods In this prospective cohort study, asymptomatic adults aged 40-85 years with a history of smoking underwent baseline LDCT screening for lung cancer between June 2000 and December 2008.

View Article and Find Full Text PDF